Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Molecular Diagnostic Techniques | 3 | 2020 | 610 | 0.880 |
Why?
|
Pathology, Molecular | 4 | 2017 | 328 | 0.780 |
Why?
|
Laboratories, Hospital | 2 | 2020 | 192 | 0.670 |
Why?
|
Colonic Neoplasms | 17 | 2020 | 2539 | 0.660 |
Why?
|
Clinical Laboratory Techniques | 2 | 2020 | 746 | 0.500 |
Why?
|
Pancreatic Cyst | 1 | 2017 | 367 | 0.440 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2013 | 431 | 0.390 |
Why?
|
Genetic Diseases, Inborn | 1 | 2016 | 604 | 0.380 |
Why?
|
Telomere | 1 | 2017 | 943 | 0.380 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1667 | 0.330 |
Why?
|
Colitis | 4 | 2020 | 1233 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 12 | 2020 | 8554 | 0.230 |
Why?
|
Pancreatic Neoplasms | 2 | 2017 | 5368 | 0.200 |
Why?
|
Azoxymethane | 7 | 2011 | 35 | 0.190 |
Why?
|
Transcription, Genetic | 2 | 2013 | 7593 | 0.190 |
Why?
|
Genetic Variation | 1 | 2016 | 6567 | 0.180 |
Why?
|
Ursodeoxycholic Acid | 3 | 2008 | 81 | 0.180 |
Why?
|
Precancerous Conditions | 4 | 2012 | 980 | 0.170 |
Why?
|
Cyclooxygenase 2 | 5 | 2009 | 597 | 0.170 |
Why?
|
Cord Blood Stem Cell Transplantation | 2 | 2013 | 305 | 0.170 |
Why?
|
MicroRNAs | 4 | 2020 | 3816 | 0.160 |
Why?
|
Utilization Review | 1 | 2020 | 382 | 0.160 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2019 | 181 | 0.150 |
Why?
|
Cost Control | 1 | 2020 | 628 | 0.150 |
Why?
|
Neoplasms | 3 | 2016 | 22173 | 0.150 |
Why?
|
Losartan | 1 | 2019 | 265 | 0.140 |
Why?
|
Genes, ras | 4 | 2013 | 654 | 0.140 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2020 | 385 | 0.140 |
Why?
|
Chemokine CXCL2 | 1 | 2016 | 106 | 0.140 |
Why?
|
Receptors, Calcitriol | 2 | 2019 | 360 | 0.130 |
Why?
|
ras Proteins | 4 | 2014 | 1054 | 0.130 |
Why?
|
Transplantation Conditioning | 3 | 2013 | 1590 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 5 | 2014 | 4514 | 0.130 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2017 | 899 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2014 | 66 | 0.120 |
Why?
|
Transforming Growth Factor alpha | 2 | 2016 | 135 | 0.120 |
Why?
|
DNA Mutational Analysis | 4 | 2016 | 4111 | 0.120 |
Why?
|
RNA | 1 | 2004 | 2725 | 0.120 |
Why?
|
Receptor Cross-Talk | 1 | 2014 | 116 | 0.110 |
Why?
|
Sarcoma, Myeloid | 1 | 2014 | 51 | 0.110 |
Why?
|
Oncogene Proteins v-myb | 1 | 2013 | 25 | 0.110 |
Why?
|
Cytogenetic Analysis | 1 | 2014 | 270 | 0.110 |
Why?
|
Asymptomatic Diseases | 1 | 2016 | 588 | 0.110 |
Why?
|
Paraffin Embedding | 1 | 2014 | 302 | 0.110 |
Why?
|
Colon | 4 | 2014 | 1792 | 0.110 |
Why?
|
Indazoles | 1 | 2015 | 304 | 0.110 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2014 | 557 | 0.100 |
Why?
|
Microsatellite Instability | 1 | 2016 | 716 | 0.100 |
Why?
|
Telomerase | 1 | 2017 | 745 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-pim-1 | 1 | 2012 | 32 | 0.100 |
Why?
|
Dextran Sulfate | 2 | 2011 | 256 | 0.100 |
Why?
|
Receptors, CXCR4 | 1 | 2016 | 727 | 0.100 |
Why?
|
Colitis, Ulcerative | 3 | 2013 | 1922 | 0.100 |
Why?
|
Microarray Analysis | 1 | 2014 | 750 | 0.090 |
Why?
|
Iodine Radioisotopes | 1 | 2015 | 1031 | 0.090 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 1115 | 0.090 |
Why?
|
Paxillin | 1 | 2010 | 86 | 0.090 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 2 | 2008 | 102 | 0.090 |
Why?
|
Lymphoma, T-Cell | 1 | 2013 | 304 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 641 | 0.090 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2010 | 89 | 0.090 |
Why?
|
DNA Copy Number Variations | 2 | 2016 | 2020 | 0.090 |
Why?
|
Proto-Oncogenes | 1 | 2011 | 321 | 0.090 |
Why?
|
Cholecalciferol | 2 | 2007 | 553 | 0.090 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2011 | 263 | 0.090 |
Why?
|
Gene Expression Profiling | 2 | 2013 | 9420 | 0.090 |
Why?
|
Incidental Findings | 1 | 2015 | 697 | 0.090 |
Why?
|
Renin-Angiotensin System | 1 | 2014 | 737 | 0.080 |
Why?
|
Haplotypes | 2 | 2013 | 2713 | 0.080 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 785 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1136 | 0.080 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2013 | 686 | 0.080 |
Why?
|
Education, Medical, Undergraduate | 1 | 2018 | 1070 | 0.080 |
Why?
|
Imidazoles | 1 | 2015 | 1180 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2020 | 1940 | 0.080 |
Why?
|
Antibodies, Neoplasm | 1 | 2009 | 281 | 0.080 |
Why?
|
Benzimidazoles | 1 | 2013 | 858 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2014 | 2827 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 2917 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 5 | 2014 | 1745 | 0.070 |
Why?
|
Adenoma | 2 | 2010 | 2163 | 0.070 |
Why?
|
Chromosome Aberrations | 1 | 2014 | 1768 | 0.070 |
Why?
|
Down-Regulation | 4 | 2020 | 2919 | 0.070 |
Why?
|
Humans | 34 | 2020 | 761596 | 0.070 |
Why?
|
Transplantation Chimera | 1 | 2009 | 594 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20100 | 0.070 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1062 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2016 | 3639 | 0.070 |
Why?
|
Mutation | 7 | 2017 | 30053 | 0.070 |
Why?
|
Stromal Cells | 1 | 2012 | 1330 | 0.070 |
Why?
|
Prognosis | 3 | 2016 | 29629 | 0.070 |
Why?
|
Lymphoma, B-Cell | 1 | 2013 | 940 | 0.070 |
Why?
|
Pancreatitis | 1 | 2013 | 1096 | 0.070 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2008 | 397 | 0.070 |
Why?
|
Curriculum | 2 | 2018 | 3743 | 0.070 |
Why?
|
Genetic Heterogeneity | 1 | 2009 | 732 | 0.060 |
Why?
|
Lymphoma | 2 | 2012 | 1901 | 0.060 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18255 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2013 | 9610 | 0.060 |
Why?
|
Vitamin D | 1 | 2019 | 3303 | 0.060 |
Why?
|
Adenoma, Villous | 1 | 2005 | 14 | 0.060 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2011 | 803 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2015 | 2650 | 0.060 |
Why?
|
Genomics | 2 | 2018 | 5821 | 0.060 |
Why?
|
Colonic Polyps | 1 | 2010 | 554 | 0.060 |
Why?
|
Cyclin D1 | 2 | 2007 | 451 | 0.060 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 687 | 0.060 |
Why?
|
Medical Oncology | 1 | 2016 | 2321 | 0.060 |
Why?
|
Hepacivirus | 1 | 2011 | 1336 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4576 | 0.060 |
Why?
|
HIV | 1 | 2011 | 1582 | 0.060 |
Why?
|
Graft Survival | 2 | 2013 | 3820 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8527 | 0.060 |
Why?
|
Up-Regulation | 4 | 2020 | 4125 | 0.060 |
Why?
|
Hematopoiesis | 1 | 2013 | 2050 | 0.050 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 13642 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5493 | 0.050 |
Why?
|
RNA, Viral | 1 | 2011 | 2846 | 0.050 |
Why?
|
Microsatellite Repeats | 1 | 2005 | 784 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 318 | 0.050 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2013 | 1728 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2013 | 2986 | 0.050 |
Why?
|
Viral Load | 1 | 2011 | 3332 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 2 | 2013 | 191 | 0.050 |
Why?
|
Mice | 12 | 2020 | 81539 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3201 | 0.050 |
Why?
|
Graft vs Host Disease | 2 | 2011 | 3029 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2015 | 2332 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2244 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3779 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 2 | 2017 | 5672 | 0.050 |
Why?
|
HCT116 Cells | 2 | 2012 | 404 | 0.050 |
Why?
|
Reference Standards | 1 | 2004 | 1003 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 8002 | 0.040 |
Why?
|
Karyopherins | 1 | 2020 | 133 | 0.040 |
Why?
|
Retroviridae | 2 | 2013 | 850 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14665 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5799 | 0.040 |
Why?
|
Animals | 16 | 2020 | 168475 | 0.040 |
Why?
|
Immunohistochemistry | 5 | 2013 | 11076 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2017 | 13381 | 0.040 |
Why?
|
Transcription Factors | 3 | 2014 | 12130 | 0.040 |
Why?
|
Isoenzymes | 1 | 2003 | 1687 | 0.040 |
Why?
|
Transplantation, Homologous | 3 | 2013 | 4807 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2010 | 3617 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5337 | 0.040 |
Why?
|
Adenocarcinoma | 3 | 2017 | 6345 | 0.040 |
Why?
|
Cadherins | 1 | 2002 | 903 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2004 | 6075 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2013 | 3615 | 0.040 |
Why?
|
Mice, Inbred A | 2 | 2007 | 246 | 0.040 |
Why?
|
RNA, Messenger | 5 | 2013 | 12794 | 0.040 |
Why?
|
Inflammation | 2 | 2020 | 10774 | 0.030 |
Why?
|
Cell Line, Tumor | 4 | 2016 | 16990 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2017 | 64685 | 0.030 |
Why?
|
Ligands | 2 | 2016 | 3272 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2017 | 2865 | 0.030 |
Why?
|
Spiro Compounds | 1 | 2016 | 68 | 0.030 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2019 | 431 | 0.030 |
Why?
|
Blotting, Western | 3 | 2011 | 5035 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2011 | 9177 | 0.030 |
Why?
|
Government Regulation | 1 | 2020 | 524 | 0.030 |
Why?
|
Models, Educational | 1 | 2018 | 373 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 2 | 2008 | 321 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2019 | 14417 | 0.030 |
Why?
|
Signal Transduction | 6 | 2016 | 23447 | 0.030 |
Why?
|
Problem-Based Learning | 1 | 2018 | 356 | 0.030 |
Why?
|
Rats, Inbred F344 | 2 | 2008 | 826 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2015 | 119 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1668 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17904 | 0.030 |
Why?
|
Interleukin-1beta | 2 | 2012 | 999 | 0.030 |
Why?
|
Intestinal Mucosa | 3 | 2013 | 3032 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2014 | 241 | 0.030 |
Why?
|
Diet | 1 | 2011 | 8075 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2013 | 6938 | 0.030 |
Why?
|
Male | 16 | 2015 | 360846 | 0.030 |
Why?
|
Immunoglobulin Isotypes | 1 | 2013 | 158 | 0.030 |
Why?
|
Formaldehyde | 1 | 2014 | 358 | 0.030 |
Why?
|
Smad4 Protein | 1 | 2013 | 191 | 0.030 |
Why?
|
Middle Aged | 11 | 2015 | 220921 | 0.030 |
Why?
|
Radiation Tolerance | 1 | 2015 | 478 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2015 | 718 | 0.030 |
Why?
|
Neoplasms, Experimental | 2 | 2011 | 1229 | 0.030 |
Why?
|
Transfection | 2 | 2012 | 5774 | 0.030 |
Why?
|
DNA Methylation | 2 | 2020 | 4399 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 546 | 0.020 |
Why?
|
Lymphocyte Subsets | 1 | 2013 | 309 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2016 | 675 | 0.020 |
Why?
|
Illinois | 1 | 2011 | 120 | 0.020 |
Why?
|
Angiotensin II | 1 | 2014 | 849 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 558 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6131 | 0.020 |
Why?
|
Aged | 9 | 2015 | 169310 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2009 | 5672 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2019 | 10451 | 0.020 |
Why?
|
Genetic Counseling | 1 | 2015 | 627 | 0.020 |
Why?
|
Quinazolines | 2 | 2008 | 1371 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2013 | 778 | 0.020 |
Why?
|
Vitamins | 1 | 2019 | 1635 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2019 | 22174 | 0.020 |
Why?
|
Mucin-6 | 1 | 2010 | 15 | 0.020 |
Why?
|
Rats | 4 | 2011 | 23741 | 0.020 |
Why?
|
Gene Amplification | 1 | 2015 | 1089 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2013 | 471 | 0.020 |
Why?
|
Adult | 9 | 2015 | 221210 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2013 | 9542 | 0.020 |
Why?
|
Apoptosis | 2 | 2019 | 9490 | 0.020 |
Why?
|
Genes, erbB-1 | 1 | 2010 | 162 | 0.020 |
Why?
|
G1 Phase | 1 | 2011 | 403 | 0.020 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 495 | 0.020 |
Why?
|
Rotation | 1 | 2011 | 517 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2013 | 727 | 0.020 |
Why?
|
Female | 12 | 2015 | 392705 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2013 | 1991 | 0.020 |
Why?
|
Adult Stem Cells | 1 | 2011 | 221 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2013 | 22176 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2012 | 656 | 0.020 |
Why?
|
Antigens, CD34 | 1 | 2011 | 658 | 0.020 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2010 | 430 | 0.020 |
Why?
|
Pneumococcal Vaccines | 1 | 2013 | 397 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6312 | 0.020 |
Why?
|
Survival Analysis | 2 | 2012 | 10090 | 0.020 |
Why?
|
Young Adult | 5 | 2014 | 59260 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 2010 | 527 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2012 | 1341 | 0.020 |
Why?
|
Cholic Acid | 1 | 2008 | 31 | 0.020 |
Why?
|
Cyclin D | 1 | 2008 | 72 | 0.020 |
Why?
|
Piperidines | 1 | 2016 | 1656 | 0.020 |
Why?
|
Cell Division | 2 | 2007 | 4465 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2011 | 1900 | 0.020 |
Why?
|
Virus Diseases | 1 | 2013 | 718 | 0.020 |
Why?
|
Hyperplasia | 1 | 2010 | 1152 | 0.020 |
Why?
|
Genetic Markers | 1 | 2013 | 2601 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2008 | 321 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2009 | 11122 | 0.020 |
Why?
|
Cell Cycle | 1 | 2014 | 2932 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6815 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1218 | 0.020 |
Why?
|
Tacrolimus | 1 | 2009 | 733 | 0.020 |
Why?
|
Cyclins | 1 | 2008 | 594 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2397 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 4021 | 0.020 |
Why?
|
Chemoprevention | 1 | 2008 | 326 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2735 | 0.020 |
Why?
|
Eosinophilia | 1 | 2010 | 560 | 0.020 |
Why?
|
CpG Islands | 1 | 2010 | 1230 | 0.020 |
Why?
|
Base Sequence | 2 | 2008 | 12441 | 0.020 |
Why?
|
Students, Medical | 1 | 2018 | 1936 | 0.010 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 615 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2015 | 58984 | 0.010 |
Why?
|
Carcinogens | 1 | 2007 | 452 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2510 | 0.010 |
Why?
|
Point Mutation | 1 | 2009 | 1595 | 0.010 |
Why?
|
DNA Primers | 1 | 2008 | 2820 | 0.010 |
Why?
|
Chromosomal Instability | 1 | 2005 | 178 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2012 | 2386 | 0.010 |
Why?
|
Bone Marrow | 1 | 2014 | 2911 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2013 | 2547 | 0.010 |
Why?
|
STAT3 Transcription Factor | 1 | 2008 | 871 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2013 | 3396 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2373 | 0.010 |
Why?
|
Translocation, Genetic | 1 | 2009 | 1393 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2009 | 1079 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2002 | 413 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6770 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3449 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2007 | 988 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5305 | 0.010 |
Why?
|
beta Catenin | 1 | 2007 | 1040 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2013 | 4544 | 0.010 |
Why?
|
Leukemia | 1 | 2009 | 1522 | 0.010 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2009 | 1609 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2013 | 1896 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3597 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2007 | 1486 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2010 | 2057 | 0.010 |
Why?
|
Physicians | 1 | 2018 | 4591 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5767 | 0.010 |
Why?
|
Biopsy | 1 | 2010 | 6766 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 12973 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5314 | 0.010 |
Why?
|
Random Allocation | 1 | 2002 | 2395 | 0.010 |
Why?
|
Pilot Projects | 1 | 2011 | 8633 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2007 | 1809 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2002 | 1626 | 0.010 |
Why?
|
Chronic Disease | 1 | 2011 | 9319 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2009 | 3964 | 0.010 |
Why?
|
Internship and Residency | 1 | 2016 | 5882 | 0.010 |
Why?
|
DNA Repair | 1 | 2005 | 2046 | 0.010 |
Why?
|
Reference Values | 1 | 2002 | 4920 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15936 | 0.010 |
Why?
|
Blood Glucose | 1 | 2009 | 6391 | 0.010 |
Why?
|
Insulin | 1 | 2009 | 6597 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2008 | 3415 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 21355 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2003 | 8181 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 18966 | 0.010 |
Why?
|
United States | 1 | 2020 | 72340 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26129 | 0.010 |
Why?
|
Disease Progression | 1 | 2008 | 13510 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 17635 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11742 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2017 | 80647 | 0.000 |
Why?
|
Time Factors | 1 | 2009 | 39969 | 0.000 |
Why?
|
Adolescent | 1 | 2009 | 88326 | 0.000 |
Why?
|